Search  in | Advanced
   Print  
Government/Advisory Meetings


IN THIS SECTION

ANALYSIS
Analysis of FDA Guidance Documents to Promote Transparency of Advisory Committees

Analysis of Draft Guidance on FDA Conflict of Interest Policy

QUICK LINKS
Ask the FDA Transcripts

Government/Regulatory Affairs
 
AABB participates in or hosts meetings in conjunction with the federal government in its role representing the interests of the transfusion medicine and cellular therapies communities. For more detail about specific meetings, click on a link below.

Advisory Committee on Blood Safety and Availability

Blood Products Advisory Committee

Cellular, Tissue and Gene Therapies Advisory Committee

Transmissible Spongiform Encephalopathies Advisory Committee

Public Meetings

FDA Liaison Meetings
Blood and Blood Components
- Cellular Therapies

Last modified on 8/27/2008 4:11:57 PM
What's New!
AABB Weekly Report - March 12, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details